Thomas Greer is a Founder and Partner of Fulcrum Equity Partners. He has over 20 years of investment, financial and operating experience. Mr. Greer was the Founder, President and CEO of Regency Healthcare, Inc. (“Regency”) a provider of hospice services throughout the Southeast. In 2006 Mr. Greer recapitalized Regency with EDG Partners, an Atlanta based private equity firm. Mr. Greer then served as Chairman of the Board up until the sale of Regency to GTCR in April 2011.
Prior to founding Regency he was Vice President of Healthcare Investment Banking for Robinson Humphrey where he worked on mergers, acquisitions, private placements and public offerings for healthcare and life science companies. Prior to Robinson Humphrey Mr. Greer was an executive in the Corporate Finance and Investment Banking Group at Eli Lilly & Company. He worked on structuring and negotiating licensing agreements, joint ventures, acquisitions and investments with domestic and international biotechnology and pharmaceutical companies. Prior to Lilly, he served as Director in KPMG’s Health Ventures practice.
Mr. Greer has served on the boards of Implantable Provider Group, Marshall Emergency Services, Inc., SunCrest Healthcare and Medical Direct Club, Fulcrum portfolio companies that had successful exits. Currently he serves on the board of directors/managers of EnduraCare Acute Care Services, LLC, Regenesis Biomedical, Inc., Five Points Healthcare LLC, Addiction Campuses LLC and Care Plus Medical LLC. Mr. Greer received his B.S. degree in Finance from Clemson University and his MBA degree from Wake Forest University.